Risk of Breakthrough Symptoms With Long-Acting Injectable Medications

NCT05473741 · clinicaltrials.gov ↗

COMPLETED

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia
Schizophrenia Relapse

Interventions

DRUG: Second Generation Long-Acting Injectable Antipsychotic Medications

Sponsor

Centre for Addiction and Mental Health

Collaborators

[object Object]